ArticleCureus2025
Evaluating Sarcopenia Prevalence in Cirrhotic Patients and Its Association With Child-Turcotte-Pugh and MELD (Model for End-Stage Liver Disease) Scores: A Cross-Sectional Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSarcopenia, defined as progressive loss of skeletal muscle strength and function, is a frequent but underrecognized complication of liver cirrhosis. It has been associated with increased morbidity and mortality, yet its prevalence and correlation with prognostic scores remain incompletely studied in the Indian population. The study aimed to determine the prevalence of sarcopenia in cirrhotic patients using handgrip strength and to evaluate the correlation between sarcopenia and liver disease severity, Child-Turcotte-Pugh (CTP) score, and Model for End-Stage Liver Disease (MELD) score.
methodsA cross-sectional study was conducted among 75 adult cirrhotic patients. Handgrip strength was measured using a handheld dynamometer, and sarcopenia was defined as <27 kg in men and <16 kg in women (European Working Group on Sarcopenia in Older People 2 (EWGSOP2) criteria). Disease severity was assessed using CTP and MELD scores. Statistical analysis included Pearson correlation, with p<0.05 considered significant.
resultsThe mean age of patients was 55.43 ± 11.54 years, with a male predominance of 54 (72%). Alcoholism was the leading etiology (n=45, 60%), followed by nonalcoholic steatohepatitis (NASH), hepatitis B virus (HBV), and hepatitis C virus (HCV). Mean MELD and CTP scores were 15.42 ± 6.32 and 8.42 ± 2.65, respectively, with most patients in CTP class B (60%). The overall mean handgrip strength was 26.69 ± 4.76 kg, higher in male patients than in female patients. The prevalence of sarcopenia was 42.7%. Handgrip strength declined across CTP classes (28.45 ± 5.65 kg in A, 26.87 ± 3.89 kg in B, and 21.65 ± 2.42 kg in C; p=0.001). Significant negative correlations were observed between handgrip strength and MELD (r = -0.412, p<0.001) as well as CTP (r = -0.358, p=0.01).
conclusionSarcopenia is highly prevalent in cirrhosis, particularly in patients with alcohol-related disease and advanced CTP class. Handgrip strength correlates strongly with MELD and CTP scores, making it a simple and effective prognostic tool in routine practice.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.